MEDICAL cannabis and CBD wellness company Materia has won EU-GMP certification for its Malta facility allowing it to begin processing and exporting cannabis flower across Europe – including the lucrative German market.
The European Union Good Manufacturing Practices (EU GMP) certification has been issued to the London-based supplier and distributor by the Malta Medicines Authority.
It has been hailed by Materia’s chief executive, Deepak Anand, as a “significant milestone.” As most European countries require the EU GMP certification for companies to import and export cannabis goods.
Mr Anand said: “We are excited to turn the engine on and showcase the full potential of a Malta-based cannabis processor to the industry, especially global partners seeking access to the European market.”
The company founded in 2018 and with a production and distribution network covering Germany, the UK, Malta and Denmark, also intends to imminently apply for a licence amendment to process cannabis extracts, leveraging the comprehensive preparatory work already completed.
Nick Pateras, Materia’s managing director, Europe, said: “We are tremendously proud to join the small group of cannabis companies with an EU GMP certified facility.
“Our team in Malta has been relentless in pursuit of this goal and adapted exceptionally to the circumstances of the last year, demonstrating why we consider them amongst the industry’s best.
“Having successfully developed our envisioned European infrastructure, commercialization now becomes our focus.”
It took over two years for Materia to develop and prepare its Malta facility for inspection to successfully gain the EU GMP certification.
